Related Experiment Video
Updated: Jul 12, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Acquired dendritic channelopathy in temporal lobe epilepsy
Christophe Bernard1, Anne Anderson, Albert Becker
1Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA. cbernard@inmed.univ-mrs.fr
Acquired channelopathies, not just inherited ones, are implicated in temporal lobe epilepsy (TLE). Reduced A-type potassium channel availability in neurons amplifies brain activity, potentially causing seizures in TLE patients.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Inherited channelopathies are known causes of neurological disorders.
- Temporal lobe epilepsy (TLE) is the most prevalent form of epilepsy in adults.
- Understanding acquired channelopathies in epilepsy is crucial for developing new treatments.
Purpose of the Study:
- To investigate acquired channelopathies in experimental temporal lobe epilepsy (TLE).
- To identify the mechanisms underlying altered neuronal excitability in TLE.
- To explore potential therapeutic targets for seizure control in TLE.
Main Methods:
- Utilized an experimental model of temporal lobe epilepsy (TLE).
- Assessed the availability and function of A-type potassium channels in CA1 pyramidal neurons.
- Investigated both transcriptional and posttranslational regulation of channel function.
- Examined the effect of extracellular signal-regulated kinase (ERK) inhibition on neuronal excitability.
Main Results:
- Demonstrated an acquired channelopathy in experimental TLE, distinct from inherited forms.
- Found decreased availability of A-type potassium channels in CA1 pyramidal neuron dendrites in TLE.
- Identified dual mechanisms: reduced channel transcription and increased channel phosphorylation by ERK.
- Showed that kinase inhibition partially restored normal dendritic excitability.
Conclusions:
- Acquired channelopathy, characterized by reduced A-type potassium channel function, contributes to increased neuronal excitability in TLE.
- These molecular alterations likely amplify neuronal activity, promoting seizure initiation and/or propagation.
- Targeting kinase pathways may offer a therapeutic strategy for managing TLE.
Related Concept Videos
Sex-linked Disorders
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mitral Valve Prolapse I: Introduction
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

